SCHEMBL9547337

SCHEMBL9547337

CCCC(Cl)OCc1cc(NC(C)=O)cc(Nc2c3ccccc3nc3ccccc23)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.55
POLB P06746 4/20 0.55
MAPT P10636 3/20 0.55
RAD52 P43351 3/20 0.55
L3MBTL1 Q9Y468 3/20 0.55
KMT2A Q03164 2/20 0.55
NPSR1 Q6W5P4 2/20 0.55
KDM1A O60341 1/20 0.55
MITF O75030 1/20 0.55
LMNA P02545 1/20 0.55
RECQL P46063 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
TOP2A P11388 10/20 0.52
TOP2B Q02880 9/20 0.52
GLA P06280 2/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9547317 0.85 TOP2A (0.60) KDM4EPOLBMAPTRAD52L3MBTL1
SCHEMBL9300986 0.82 POLB (0.55) KDM4EPOLBMAPTRAD52L3MBTL1
SCHEMBL9300054 0.82 TOP2A (0.74) KDM4EPOLBMAPTRAD52L3MBTL1
SCHEMBL9300052 0.81 TOP2A (0.73) KDM4EPOLBMAPTRAD52L3MBTL1
SCHEMBL9547343 0.80 KDM4E (0.53) KDM4EPOLBMAPTRAD52L3MBTL1
SCHEMBL9300059 0.79 TOP2A (0.61) KDM4EPOLBMAPTRAD52L3MBTL1
SCHEMBL9300852 0.79 KMT2A (0.72) KDM4EPOLBMAPTRAD52L3MBTL1
SCHEMBL9300216 0.78 TOP2A (0.56) KDM4EPOLBMAPTRAD52L3MBTL1
SCHEMBL9299881 0.77 TOP2A (0.59) KDM4EPOLBMAPTRAD52L3MBTL1
SCHEMBL9300912 0.77 TOP2A (0.53) KDM4EPOLBMAPTRAD52L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993023049-A1 3-(9-ACRIDINYLAMINO)-5-HYDROXYMETHYLANILINE DERIVATIVES AS ANTICANCER AGENTS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-11-25 WO claimed